HedgeChatter

  • Home /
  • Tag Archives

ISIS

9:32 am ISIS Pharm reports final Phase 2 data on ISIS-APOCIII Rx in patients with high triglycerides taking fibrates; reductions of up to 64% in triglycerides achieved

moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

April 1, 2014 Bystocknews , Comments Off on 9:32 am ISIS Pharm reports final Phase 2 data on ISIS-APOCIII Rx in patients with high triglycerides taking fibrates; reductions of up to 64% in triglycerides achieved read more

7:04 am ISIS Pharm announces antisense targeting Of HBV produces dose-dependent reductions in hepatitis B virus in an animal model of HBV; data to be presented in April at the European Association for the Study of the Liver Meeting

moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

March 25, 2014 Bystocknews , Comments Off on 7:04 am ISIS Pharm announces antisense targeting Of HBV produces dose-dependent reductions in hepatitis B virus in an animal model of HBV; data to be presented in April at the European Association for the Study of the Liver Meeting read more

Could Isis Threaten Regeneron and Novartis?

moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

March 22, 2014 Bystocknews , Comments Off on Could Isis Threaten Regeneron and Novartis? read more

Jim Cramer’s ‘Mad Money’ Recap: Stop Panicking

[at TheStreet] – Ukraine is just another in a long list of foreign crises that have the markets operating on emotion instead of logic, Cramer says. moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

March 4, 2014 Bystocknews , Comments Off on Jim Cramer’s ‘Mad Money’ Recap: Stop Panicking read more

ISIS Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx

[at noodls] – CARLSBAD, Calif., March 3, 2014/PRNewswire/ — Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the initiation … moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on ISIS Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx read more